Surat is reporting over 50 cases of mucormycosis, a fungal infection that COVID patients on oxygen and those who are diabetic are prone to following recovery from the disease.
So far 250 people have been operated on for the black fungus of which 50 have lost their sight while 4 have lost their lives. Surat at present has 1000 patients under treatment for the disease.
Surat Civil Hospital alone has 25 patients with mucormycosis.
Mucormycosis in Gujarat
As more people go on ventilator and oxygen support in the second wave of COVID, Gujarat is battling a surge in mucormycosis infection and the surge in demand for injection to treat the disease.
Amphotericin-B injections are used to treat the condition and each injection costs up to Rs7000 and depending on the severity of the condition the cost of treatment may go up.
The number of cases is on the rise in Saurashtra with many patients coming to Rajkot to get treated. The Gujarat government has ordered 5,000 Amphotericin-B injections worth Rs 3.12 crore for the treatment of patients.
Gujarat has been reporting several instances of COVID patients developing mucormycosis, which is often fatal for those who are transplant patients, in ICU, and have poor immunity.
Civil Hospital in Ahmedabad alone has reported 67 such patients in the last 20 days. Earlier, AIIMS chief Dr Randeep Guleria had said that a high dosage of some drugs used for COVID which was not justified was lowering the immunity of patients making them vulnerable to secondary infections.
The state has also set up separate wards for the treatment of the disease in all civil hospitals, especially in Ahmedabad, Bhavnagar, Jamnagar Rajkot, Surat, and Vadodara.
To read the latest news in Gujarati click here